The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry providing solutions from small to the most complex customized workflows. We are helping biotech scientists and engineers across the entire globe to develop and manufacture medications from the first idea to production. So, more people will have access to better medicine.
In 2017, Sartorius extended its BioAnalytics portfolio with the acquisition of Essen BioScience Inc., a pioneer and leader in the field of cell-based assays and instrumentation used for drug discovery and basic research applications.
Founded in Ann Arbor, Michigan in 1996, Essen BioScience develops and manufactures instruments, software, reagents, and consumables that enable researchers to remotely image and quantify a wide variety of cellular processes over time. Such novel analytical methods are crucial to enable scientific progress in the rapidly advancing areas of immuno-oncology, antibody discovery, stem cell research, and beyond.
At this channel, we will keep you updated on the newest developments and most exciting trends in the field, while also giving insights into technical details and performance of our Incucyte® product range.
Empower Your Research with Incucyte® Live-Cell Analysis
The Incucyte Live-Cell Analysis system is designed to efficiently capture cellular changes where they happen—in the incubator. Capture high-resolution images and record data in real time over days, weeks, or even months. From proliferation assays to immune killing of tumor spheroids, this flexible system enables users to observe and quantify complex biological changes in real time. Integrated software simplifies data analysis to speed time to answer while producing publication-quality graphs and plots.
